KRISTEN RINKENBERG: Open Payments
NPI 1700962321 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 28 payments from 12 companies in 2025. Trend: 2023 $223 · 2024 $31 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $128 |
| ABBVIE INC. | 6 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
| PFIZER INC. | 2 | $51 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Ardelyx, Inc. | 1 | $21 |
Products named: TREMFYA, RINVOQ, ZENPEP, VOQUEZNA, VELSIPITY, DUPIXENT, GATTEX, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
